Logo image of DLE.I

DATALEX PLC (DLE.I) Stock Fundamental Analysis

DUB:DLE - Euronext Dublin - IE0000527006 - Common Stock - Currency: EUR

0.4  +0.05 (+14.29%)

Fundamental Rating

1

DLE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 95 industry peers in the Software industry. DLE has a bad profitability rating. Also its financial health evaluation is rather negative. DLE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DLE had negative earnings in the past year.
DLE had a negative operating cash flow in the past year.
DLE had negative earnings in each of the past 5 years.
In multiple years DLE reported negative operating cash flow during the last 5 years.
DLE.I Yearly Net Income VS EBIT VS OCF VS FCFDLE.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -60.77%, DLE is doing worse than 85.26% of the companies in the same industry.
Industry RankSector Rank
ROA -60.77%
ROE N/A
ROIC N/A
ROA(3y)-47.09%
ROA(5y)-45.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DLE.I Yearly ROA, ROE, ROICDLE.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400

1.3 Margins

DLE's Gross Margin of 35.89% is on the low side compared to the rest of the industry. DLE is outperformed by 74.74% of its industry peers.
In the last couple of years the Gross Margin of DLE has grown nicely.
The Profit Margin and Operating Margin are not available for DLE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y28.41%
DLE.I Yearly Profit, Operating, Gross MarginsDLE.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

DLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DLE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DLE has more shares outstanding
The debt/assets ratio for DLE is higher compared to a year ago.
DLE.I Yearly Shares OutstandingDLE.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
DLE.I Yearly Total Debt VS Total AssetsDLE.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

DLE has an Altman-Z score of -3.16. This is a bad value and indicates that DLE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.16, DLE is doing worse than 81.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC7.38%
DLE.I Yearly LT Debt VS Equity VS FCFDLE.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.31 indicates that DLE may have some problems paying its short term obligations.
DLE has a Current ratio of 0.31. This is amonst the worse of the industry: DLE underperforms 87.37% of its industry peers.
A Quick Ratio of 0.31 indicates that DLE may have some problems paying its short term obligations.
DLE has a Quick ratio of 0.31. This is amonst the worse of the industry: DLE underperforms 87.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
DLE.I Yearly Current Assets VS Current LiabilitesDLE.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.26% over the past year.
Looking at the last year, DLE shows a quite strong growth in Revenue. The Revenue has grown by 12.26% in the last year.
Measured over the past years, DLE shows a decrease in Revenue. The Revenue has been decreasing by -8.52% on average per year.
EPS 1Y (TTM)38.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.51%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y0.96%
Revenue growth 5Y-8.52%
Sales Q2Q%2.67%

3.2 Future

The Earnings Per Share is expected to grow by 52.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, DLE will show a quite strong growth in Revenue. The Revenue will grow by 8.14% on average per year.
EPS Next Y-6.98%
EPS Next 2Y29.4%
EPS Next 3Y52.55%
EPS Next 5YN/A
Revenue Next Year-3.22%
Revenue Next 2Y4.77%
Revenue Next 3Y8.14%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLE.I Yearly Revenue VS EstimatesDLE.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
DLE.I Yearly EPS VS EstimatesDLE.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLE.I Price Earnings VS Forward Price EarningsDLE.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DLE.I Per share dataDLE.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

DLE's earnings are expected to grow with 52.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.4%
EPS Next 3Y52.55%

More info and screens

0

5. Dividend

5.1 Amount

DLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DATALEX PLC

DUB:DLE (4/25/2025, 7:00:00 PM)

0.4

+0.05 (+14.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)06-18 2025-06-18/amc
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners11.64%
Ins Owner ChangeN/A
Market Cap75.26M
Analysts80
Price Target0.48 (20%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.14
BVpS-0.11
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.89%
FCFM N/A
ROA(3y)-47.09%
ROA(5y)-45.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y28.41%
F-Score5
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.95%
Cap/Sales 3.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -3.16
F-Score5
WACC7.38%
ROIC/WACCN/A
Cap/Depr(3y)118%
Cap/Depr(5y)91.7%
Cap/Sales(3y)8.62%
Cap/Sales(5y)6.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.51%
EPS Next Y-6.98%
EPS Next 2Y29.4%
EPS Next 3Y52.55%
EPS Next 5YN/A
Revenue 1Y (TTM)12.26%
Revenue growth 3Y0.96%
Revenue growth 5Y-8.52%
Sales Q2Q%2.67%
Revenue Next Year-3.22%
Revenue Next 2Y4.77%
Revenue Next 3Y8.14%
Revenue Next 5YN/A
EBIT growth 1Y53.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.88%
EBIT Next 3Y37.69%
EBIT Next 5YN/A
FCF growth 1Y72.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.68%
OCF growth 3YN/A
OCF growth 5YN/A